Despite on-going evolution and iteration of drug-eluting stent (DES) technology, the
prevalence of in-stent restenosis (ISR) remains relatively unchanged, encompassing≈ 10 …

The introduction of the drug-eluting stent (DES) proved to be an important step forward in
reducing rates of restenosis and target lesion revascularization after percutaneous coronary …

In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …

Next is a granulation or cellular proliferation phase. Growth factors are subsequently
released from platelets, leukocytes, and SMCs, which stimulate migration of SMCs from the …

Background—The effectiveness of sirolimus-eluting stents in unselected patients treated in
the daily practice is currently unknown. Methods and Results—Sirolimus-eluting stent …

Background—We used intravascular ultrasound (IVUS) to evaluate recurrence after
sirolimus-eluting stent (SES) implantation treatment of in-stent restenosis (ISR). Methods …

Background—The factors associated with the occurrence of restenosis after sirolimus-
eluting stent (SES) implantation in complex cases are currently unknown. Methods and …

Oligometastatic disease represents a clinical and anatomical manifestation between
localised and polymetastatic disease. In prostate cancer, as with other cancers, recognition …

Advances in stent technology and the design of endovascular devices with thinner struts,
anti‐inflammatory and antithrombotic polymers, and better drug kinetics have enhanced the …

Objectives: This study sought to investigate the frequency, predictors, and detailed
qualitative and quantitative assessment of optical coherence tomography (OCT)-detected …